* FDA staff: Pfizer cancer drug showed uncertain benefits * Staff also question Novartis cancer drug data * FDA panel set to review both drugs on Tuesday (Adds FDA comments on Novartis drug, add...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 2-Pfizer drug's pancreatic benefit is unclear-US FDA
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account